RAPEZZI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 20.290
AS - Asia 14.711
EU - Europa 13.038
AF - Africa 1.001
SA - Sud America 807
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 6
Totale 49.886
Nazione #
US - Stati Uniti d'America 20.069
VN - Vietnam 4.391
SG - Singapore 4.049
CN - Cina 3.366
GB - Regno Unito 3.165
IT - Italia 2.495
DE - Germania 1.752
SE - Svezia 1.444
HK - Hong Kong 957
FR - Francia 873
RU - Federazione Russa 744
IN - India 696
UA - Ucraina 622
BR - Brasile 589
IE - Irlanda 488
NL - Olanda 355
ZA - Sudafrica 301
EE - Estonia 260
JP - Giappone 257
CI - Costa d'Avorio 250
TG - Togo 215
FI - Finlandia 210
BD - Bangladesh 155
CA - Canada 147
KR - Corea 147
BG - Bulgaria 130
JO - Giordania 116
PH - Filippine 101
AR - Argentina 98
BE - Belgio 97
CH - Svizzera 87
SC - Seychelles 79
PL - Polonia 78
NG - Nigeria 71
TH - Thailandia 70
IR - Iran 53
ID - Indonesia 49
IQ - Iraq 46
GR - Grecia 45
MX - Messico 41
TW - Taiwan 40
AT - Austria 39
PK - Pakistan 39
TR - Turchia 33
EC - Ecuador 31
ES - Italia 27
AU - Australia 26
CL - Cile 26
UZ - Uzbekistan 26
RO - Romania 21
LT - Lituania 20
MY - Malesia 20
CO - Colombia 18
MA - Marocco 17
SA - Arabia Saudita 17
LB - Libano 16
PY - Paraguay 16
HR - Croazia 15
EG - Egitto 14
DZ - Algeria 11
KE - Kenya 11
PE - Perù 11
TN - Tunisia 10
AZ - Azerbaigian 9
NP - Nepal 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
HU - Ungheria 8
MD - Moldavia 8
AL - Albania 7
ET - Etiopia 7
HN - Honduras 7
IL - Israele 7
JM - Giamaica 7
NO - Norvegia 7
UY - Uruguay 7
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
GE - Georgia 5
PT - Portogallo 5
SN - Senegal 5
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
GT - Guatemala 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
GH - Ghana 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LY - Libia 2
MK - Macedonia 2
Totale 49.850
Città #
Singapore 2.812
Southend 2.757
Ashburn 2.126
Fairfield 2.123
Chandler 1.358
San Jose 1.281
Woodbridge 1.081
Houston 982
Seattle 934
Hong Kong 915
Wilmington 890
Ho Chi Minh City 885
Santa Clara 780
Cambridge 771
Dong Ket 771
Ann Arbor 765
Hanoi 750
Princeton 668
Dublin 486
Beijing 482
Boardman 447
Jacksonville 319
Lauterbourg 306
Westminster 298
Nanjing 284
Padova 277
Los Angeles 274
Bologna 272
Hefei 265
Abidjan 250
New York 240
Lomé 215
Tokyo 212
Berlin 200
Milan 167
Saint Petersburg 167
Bremen 156
Buffalo 152
Helsinki 148
Munich 148
Council Bluffs 136
Turin 133
Jinan 132
Rome 132
Frankfurt am Main 126
Sofia 125
Shenyang 121
Da Nang 116
São Paulo 116
Amman 113
San Diego 109
Redondo Beach 103
Haiphong 102
Dearborn 98
Seoul 98
Nanchang 97
Dallas 96
Changsha 95
Brussels 94
Hebei 87
Tianjin 85
Guangzhou 83
Abeokuta 69
Shanghai 66
Chicago 65
Jiaxing 63
Bern 62
Medford 62
Mülheim 61
The Dalles 60
Zhengzhou 58
Turku 57
Toronto 56
Phoenix 55
Florence 52
London 52
Des Moines 50
Naples 49
Orem 48
Warsaw 48
Hangzhou 46
Hải Dương 46
Falkenstein 45
Haikou 44
Norwalk 43
Paris 43
Yubileyny 43
San Francisco 42
Redwood City 41
Falls Church 40
Redmond 39
Olalla 38
Biên Hòa 36
Shenzhen 36
Atlanta 34
Johannesburg 34
Ningbo 31
Taiyuan 31
Mahé 30
Nuremberg 30
Totale 32.616
Nome #
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 617
ATEROMASIA DELL'ARCO AORTICO COME FATTORE PREDITTIVO DI EMBOLIA CEREBRALE DURANTE LE PROCEDURE DI STENTING CAROTIDEO. STUDIO PROSPETTICO CON ECOCARDIODOPPLER TRANSESOFAGEO A DIFFUSIONE E RISONANZA MAGNETICA 538
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy 400
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 363
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 318
Ventricular remodeling in Loeffler endocarditis: Implications for therapeutic decision making. 312
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 309
Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis. 270
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 258
Usefulness and limitations of (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. 258
Noninvasive etiologic diagnosis of cardiac amyloidosis using (99m)tc-3,3-diphosphono-1,2-propanodicarboxylic Acid scintigraphy. 251
Atrial fibrillation in amyloidotic cardiomyopathy: Prevalence, incidence, risk factors and prognostic role 251
Parodoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventriculat noncompaction 247
Sempre oscura mi fu quest'aVR. L'insospettabile ricchezza di una derivazione dimenticata 247
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 242
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 239
Risk Factors for diagnostic delay in acute aortic dissection. 238
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 238
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 235
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 232
Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. 230
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 228
Amiloidosi ereditaria da mutazione della transtiretina: caratterizzazione dei casi con interessamento cardiaco esclusivo o prevalente 227
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 226
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy 226
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy. 225
Carotid revascularization in patients with ongoing oral anticoagulant therapy: the advantages of stent placement. 224
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 223
The elusive link between aortic wall histology and echocardiographic anatomy in bicuspid aortic valve: implications for prophylactic surgery 220
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 219
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 219
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. 218
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 218
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 217
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 216
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 212
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 211
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 210
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
Cardiac amyloidosis: the great pretender 209
Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. 207
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 207
Different types of cardiomyopathy associated with isolated ventricular noncompaction 206
Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy 205
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 205
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 204
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 204
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. 203
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 203
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 203
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 201
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 200
Cardiac involvement in hereditary-transthyretin related amyloidosis. 199
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 199
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 198
Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis 198
An unusual case of a congenital aorto-left atrial tunnel. 198
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 197
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. 196
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 196
Age and heart transplantation: results from a heart failure management unit. 195
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 194
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 194
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 193
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 191
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis∗ 191
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 191
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. 190
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 190
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 190
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy 189
Accuracy of non-invasive techniques for diagnosis of coronary artery disease and prediction of cardiac events in patients with left bundle branch block: a meta-analysis. 188
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 188
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 188
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 187
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 187
Selective myocardial uptake of Tc-99m-DPD in transthyretin-related amyloidosis: Implications for recognition of cardiac involvement and differential diagnosis with AL amyloidosis 186
Brain microbleeds 12 Years after orthotopic liver transplantation in Val30Met amyloidosis 186
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 186
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 185
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 185
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 184
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 184
The empowerment of translational research: lessons from laminopathies. 184
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 184
Gadolinium enhancement cardiac magnetic resonance in cardiac amyloidosis: clinical, pathophysiologic an hystologic correlations. 182
Genotype-phenotype correlations in amyloidotic cardiomyopathy. 181
Usefulness of 99-Tc DPD scintigraphy and identification of transthyretin-related cardiac amyloidosis 180
Transthyretin-related amyloidoses and the heart: a clinical overview. 180
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 179
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 178
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 178
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 178
The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms 177
Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes 177
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 176
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 176
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 176
L'eziologia dell'amiloidosi condiziona i meccanismi dello scompenso cardiaco della cardiomiopatia amiloidotica 176
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms 175
Totale 21.858
Categoria #
all - tutte 134.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.491 0 0 0 0 0 0 0 0 0 0 0 1.491
2021/20225.728 503 284 368 541 528 326 157 364 235 358 1.109 955
2022/20236.374 639 860 356 920 482 490 163 355 1.159 181 456 313
2023/20241.768 118 318 142 161 149 416 95 72 46 121 66 64
2024/20256.231 255 1.032 532 540 1.079 270 329 201 85 439 187 1.282
2025/202614.319 1.336 1.081 1.142 978 1.631 857 1.315 894 2.940 1.161 527 457
Totale 50.750